Stockreport

Santen and TRACON Discontinue Development of DE-122 for Wet Age-Related Macular Degeneration

TRACON PHARMS INC  (TCON) 
Last tracon pharms inc earnings: 2/27 04:03 pm Check Earnings Report
US:NASDAQ Investor Relations: traconpharma.com
PDF OSAKA, Japan and SAN DIEGO, March 09, 2020 (GLOBE NEWSWIRE) -- Santen Pharmaceutical Co., Ltd. (Head Office: Osaka; hereinafter, “Santen”) and TRACON Pharmaceuticals, [Read more]